RRMS

Latest

RRMS

This diagram shows how ms affects the body

·May 8, 2019·4 min read

A new culprit for multiple sclerosis relapses

Injecting extracellular vesicles from healthy mice into mice that had an MS-like disease resulted in the development of a relapse-remitting disease and active CD8+ cells, similar to that seen in human patients with multiple sclerosis. Examining the EVs in mice and humans with MS, researchers identified they contained fibrinogen, a protein normally associated with blood clotting and wound healing. According to researchers, the EVs with fibrinogen appear to activate the CD8+ immune cells. The findings could help with the development of new treatments for RRMS.

This shows the differences in ceramide levels in those with a higher BMI

Featured Genetics Neurology Neuroscience Open Neuroscience Articles

·April 11, 2019·5 min read

Body mass index may play a significant role in the progression of multiple sclerosis

Obesity and a higher body mass index negatively impacts the progression of Multiple Sclerosis. Ceramides are more abundant in the blood of those who are overweight. The ceramides enter inside the nucleus of monocytes, causing proliferation. The increased number of monocytes travel back to the brain, causing more damage for those with RRMS.

Featured Genetics Neurology

·March 26, 2018·6 min read

Stem Cell Treatment Stabilizes Disease and Reduces Disability in Multiple Sclerosis

Researchers reveal that a year after receiving autologous haematopoietic stem cell transplantation for relapse remitting multiple sclerosis, almost all of the patients showed no signs of the disease and the level of their disability was significantly improved.

Featured Neurology Open Neuroscience Articles

·December 20, 2017·5 min read

Antidepressant May Help Combat the Course of Multiple Sclerosis

A new Nature Communications study reports the antidepressant Clomipramine may relieve symptoms of primary progressive multiple sclerosis.

Featured Neurology Open Neuroscience Articles

·October 30, 2017·5 min read

Powerful Biomarker of Multiple Sclerosis Discovered

Researchers have identified a unique biomarker in the blood of people with Multiple Sclerosis. Using a simple blood test, researchers were able to identify those with MS and discriminate between people at different stages of the disease.

Featured Neurology

·August 1, 2017·4 min read

Resistance Training May Slow Multiple Sclerosis Progression

Researchers report resistance training may slow down the progression of multiple sclerosis by protecting the nervous system against the disease.

Featured Neurology

·May 15, 2017·4 min read

Potential Risk of Common Multiple Sclerosis Treatment Discovered

Researchers detail possible adverse reactions, from stroke to depression, for a common medication given to help treat multiple sclerosis.

Image shows a brain scan of a person with multiple sclerosis.

Featured Neurology

·March 29, 2017·7 min read

New Multiple Sclerosis Drug, Backed by 40 Years of Research, Could Halt Disease

FDA approves a new drug to treat both relapsing-remitting multiple sclerosis and primary progressive MS.

Featured Genetics Neurology

·February 5, 2017·5 min read

Stem Cell Transplants May Induce Long-Term Remission of Multiple Sclerosis

A new study reveals immunosupressive therapy coupled with stem cell transplantation can induce sustained remission in RRMS patients.

Featured Neurology Open Neuroscience Articles

·January 9, 2017·5 min read

Breakthrough in Multiple Sclerosis Treatment

Clinical trials show that a new drug called ocrelizumab can reduce attacks in people with RRMS, and can reduce new symptom development in patients with primary progressive multiple sclerosis.

Featured Neurology

·October 13, 2016·4 min read

Multiple Sclerosis Drug May Reverse Some Physical Disability

According to researchers, a drug used to treat multiple sclerosis could help to reverse some of the physical disabilities associated with the disease.